Ignite Creation Date:
2025-12-24 @ 4:47 PM
Ignite Modification Date:
2025-12-29 @ 8:42 PM
Study NCT ID:
NCT02119650
Status:
TERMINATED
Last Update Posted:
2018-02-13
First Post:
2014-04-17
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Ruxolitinib in Combination With Pemetrexed/Cisplatin in Non Small Cell Lung Cancer
Sponsor:
Incyte Corporation
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-02-11
Start Date Type:
ACTUAL
Primary Completion Date:
2016-02-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-06-21
Completion Date Type:
ACTUAL
First Submit Date:
2014-04-17
First Submit QC Date:
None
Study First Post Date:
2014-04-22
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2017-02-10
Results First Submit QC Date:
None
Results First Post Date:
2017-06-14
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-01-15
Last Update Post Date:
2018-02-13
Last Update Post Date Type:
ACTUAL